Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome
Open Access
- 30 August 2017
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 9 (1) , 1-13
Abstract
Aberrant CpG island methylation has been increasingly recognized as a common event in myelodysplastic syndrome (MDS). To date, most of the previous studies of miR-124 in MDS have focused on epigenetic changes and little is known about the underlying mechanism through which miR-124 regulates CDK6 expression. In the present study, we employed pyrosequencing analysis to quantify the methylation levels of upstream regions of the miR-124 genes (miR-124-1, miR-124-2 and miR-124-3) in 56 primary MDS patients. We found the three miR-124 genes were methylated in MDS patients. Univariate analysis revealed that the World Health Organization (WHO) classification, marrow blast count, karyotype, International Prognostic Scoring System (IPSS), mean corpuscular volume, as well as high methylation of miR-124-1, miR-124-2 and miR-124-3 were significantly related to overall survival. In leukaemia-free survival, patients who were older and had an advanced WHO classification, high marrow blast counts, high IPSS risk and high methylation of miR-124-1 and miR-124-2 progressed rapidly to acute myeloid leukaemia. Multivariate analysis demonstrated that high methylation of miR-124-3 was an independent factor of overall survival. Median survival of patients with high miR-124-3 methylation was significantly shorter (7.6 months) than patients with low methylation (32.7 months; P = 0.010). A functional study revealed that silencing of miR-124 resulted in upregulation of its target gene, cyclin dependent kinase CDK6, which in turn promoted cell proliferation in the MDS cell line SKM-1. High methylation of miR-124-3 predicts shorter survival for patients with MDS, which may be a useful prognostic marker in MDS.Keywords
Funding Information
- National Natural Science Foundation of China (81100342, 81270583, 81270591)
This publication has 39 references indexed in Scilit:
- Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AMLBlood, 2012
- Epigenetic Inactivation of the miR-124-1 in Haematological MalignanciesPLOS ONE, 2011
- Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancerMolecular Cancer, 2010
- DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic SyndromesJournal of Clinical Oncology, 2010
- DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: Its possible involvement in the formation of epigenetic field defectInternational Journal of Cancer, 2009
- Epigenetic Regulation of MicroRNAs in Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2009
- Biogenesis of small RNAs in animalsNature Reviews Molecular Cell Biology, 2009
- Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer CellsCancer Research, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- MicroRNAsCell, 2004